TERUMO CORP./ JP3546800008 /
| 2024-07-27 1:03:54 PM | Chg. 0.000 | Volume | Bid1:03:54 PM | Ask1:03:54 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 16.000EUR | 0.00% | - Turnover: - |
16.000Bid Size: - | 16.400Ask Size: - | 24.04 bill.EUR | - | - |
GlobeNewswire
06-10
Over 80 Organizations Kick Off Blood Advocacy Week by Urging Congress to Support the Blood Supply as...
GlobeNewswire
06-04
Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Le...
GlobeNewswire
05-13
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
05-09
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
04-30
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Paten...
GlobeNewswire
04-30
Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacem...
GlobeNewswire
04-02
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
GlobeNewswire
03-26
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of D...
GlobeNewswire
03-13
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy ...
GlobeNewswire
03-06
Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemod...
GlobeNewswire
02-26
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambu...
GlobeNewswire
02-20
TransPerfect’s GlobalLink/Adobe Experience Manager (AEM) Integration Adds 30+ Global Brands in 2023
GlobeNewswire
01-08
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pace...
GlobeNewswire
2023-11-13
Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-09-19
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for...
GlobeNewswire
2022-02-03
Applied Science, Inc. Announces New Vice President of Sales, Marketing & Customer Care, Ral Trujillo
GlobeNewswire
2021-12-17
Sigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapie...
GlobeNewswire
2021-11-18
Terumo Corporation and Diabeloop SA Enter Into Comprehensive Strategic Partnership Agreement to Expa...
GlobeNewswire
2021-11-05
Orchestra BioMed™ Announces Presentations at TCT 2021 of Positive Long-Term Clinical Results from th...
